We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current APYX market cap is 76.91M. The company's latest EPS is USD -0.6692 and P/E is -3.32.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.11M | 12.61M | 12.14M | 13.57M | 11.98M |
| Operating Income | -5.78M | -5.93M | -5.61M | -3.93M | -4.64M |
| Net Income | -5.76M | -6.05M | -3.48M | -994k | -4.63M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.69M | 28.24M | 27.71M | 48.52M | 44.51M |
| Operating Income | -13.6M | -20.87M | -20.08M | -14.45M | -23.56M |
| Net Income | 64.01M | -19.71M | -11.9M | -15.17M | -23.18M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 55.27M | 51.78M | 56.78M | 62.43M | 59.45M |
| Total Liabilities | 13.05M | 13.98M | 20.57M | 25.7M | 25.86M |
| Total Equity | 42.22M | 37.79M | 36.21M | 36.73M | 33.59M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 95.61M | 84.75M | 74.11M | 68.72M | 51.78M |
| Total Liabilities | 7.84M | 13.49M | 10.25M | 14.71M | 13.98M |
| Total Equity | 87.77M | 71.26M | 63.86M | 54.01M | 37.79M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.75M | -20.28M | -1.88M | -6.73M | -3.04M |
| Investing | -868k | -1.01M | -110k | 7M | 6.83M |
| Financing | 227k | 217k | 8.11M | 8.16M | 8.32M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.01M | -18.48M | -16.07M | -10.45M | -20.28M |
| Investing | 29.3M | 60.54M | -581k | -723k | -1.01M |
| Financing | -2.49M | 147k | -73k | 24k | 217k |
| Market Cap | 76.91M |
| Price to Earnings Ratio | -3.32 |
| Price to Sales Ratio | 1.73 |
| Price to Cash Ratio | 7.55 |
| Price to Book Ratio | 2.04 |
| Dividend Yield | - |
| Shares Outstanding | 34.64M |
| Average Volume (1 week) | 215.68k |
| Average Volume (1 Month) | 259.58k |
| 52 Week Change | 26.86% |
| 52 Week High | 7.97 |
| 52 Week Low | 1.41 |
| Spread (Intraday) | 0.02 (0.93%) |
| Company Name | Apyx Medical Corporation |
| Address |
united corporate services, inc dover, delaware 19904 |
| Website | https://www.apyxmedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
